Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Pediatría Atención Primaria
versión impresa ISSN 1139-7632
Resumen
LEGANES VILLANUEVA, Carlos et al. Neuroleptic malignant syndrome in pediatrics. A case report. Rev Pediatr Aten Primaria [online]. 2021, vol.23, n.89, pp.71-74. Epub 09-Mayo-2022. ISSN 1139-7632.
Abstract
Neuroleptic malignant syndrome is a pediatric emergency with high morbidity and mortality, related to an alteration of the dopaminergic neurotransmission system. It is characterized by hyperthermia along with muscular hypertonia, dysautonomia, and altered level of consciousness.
An early diagnosis is essential to prevent common complications such as bronchoaspiration, wear, bedsores, infectious processes, and neuropsychiatric changes. Treatment should include general support measures and symptomatic pharmacological therapy.
Although most of the cases described correspond to the adulthood, it has also been described in children and adolescents. We present a case of neuroleptic malignant syndrome in a 12-year-old adolescent with encephalopathy and spastic tetraparesis secondary to the cessation of baclofen administration.
Palabras clave : Dopamine; Hypertonia; Neuroleptic; Neuroleptic malignant syndrome.